Metraipolis › archive › dc_259161ed8bb1

Neutrophils remain detrimentally active in hydroxyurea-treated patients with sickle cell disease — Europe PMC PMID:31869367

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/31869367
DOI
10.1371/journal.pone.0226583
License (as archived)
CC0-1.0
Archived
2026-11-09T21:17:48.192Z
SHA-256 of the archived text
7c9115d3723a0b1cb7552dea87a06c3af11a1ce736a9fd5353f45827e73f997f
Stable URL of this page
https://metraipolis.com/documento/dc_259161ed8bb1

How to cite

Neutrophils remain detrimentally active in hydroxyurea-treated patients with sickle cell disease — Europe PMC PMID:31869367 — Europe PMC (en), https://europepmc.org/article/MED/31869367 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_259161ed8bb1 (Metraipolis archive dc_259161ed8bb1, sha256 7c9115d3723a0b1cb7552dea87a06c3af11a1ce736a9fd5353f45827e73f997f)
BibTeX
@misc{dc259161ed8bb1,
  title = {Neutrophils remain detrimentally active in hydroxyurea-treated patients with sickle cell disease — Europe PMC PMID:31869367},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/31869367},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_259161ed8bb1; sha256 7c9115d3723a0b1cb7552dea87a06c3af11a1ce736a9fd5353f45827e73f997f},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/31869367. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Neutrophilia is a feature of sickle cell disease (SCD) that has been consistently correlated with clinical severity and has been shown to remain highly activated even at steady state. In addition to induction of fetal hemoglobin (HbF), hydroxyurea (HU) leads to reduction in neutrophil count and their adhesion properties, which contributes to the clinical efficacy of HU in SCD. Although HU reduces the frequency and severity of acute vaso-occlusive crises (VOCs) and chest syndrome, HU therapy does not abolish these acute clinical events. In this study we investigated whether neutrophils in SCD patients whilst on HU therapy retained features of detrimental pro-inflammatory activity. Freshly isolated neutrophils from SCD patients on HU therapy at steady state and from ethnic-matched healthy controls were evaluated ex vivo for their degranulation response and production of neutrophil extracellular traps (NETs). Unstimulated SCD patient neutrophils already produced NETs within 30 minutes, compared to none for healthy neutrophils, and by 4 hours, these neutrophils produced significantly more NETs than the control neutrophils (P = 0.0079**). Higher numbers of neutrophils from SCD patients also showed higher degree of degranulation-related intracellular features compared to healthy neutrophils, including rough-textured cellular membranes (P = 0.03*), double-positivity for F-Actin and CD63 (P = 0.02*) and re-located CD63 within cytoplasm more efficiently than their healthy counterparts (P = 0.02*). The neutrophils from SCD donors released more myeloperoxidase (P = 0.02*) in the absence of any trigger. Our data showed that neutrophils from patients with SCD at steady state remained active during hydroxyurea treatment and are likely to be able to contribute to the SCD pro-inflammatory environment.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2019 (prima pubblicazione 2019-12-23).
Identificativi: PMID 31869367 · PMCID PMC6927657 · DOI 10.1371/journal.pone.0226583.
Descrittori MeSH principali: Cell Degranulation.
Pagina: https://europepmc.org/article/MED/31869367 — https://doi.org/10.1371/journal.pone.0226583. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-09T21:14:27.872Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.